Our Company

Providing Innovations in Gluten Science

Glutagen is a biopharmaceutical company based in Melbourne, Australia. Glutagen’s primary focus is to provide clinically-relevant and scientific evidence-based complementary medicines to support the health and wellbeing of individuals with gluten-related issues. Glutagen’s holistic approach to personalised health involves the provision of the highest quality products, including its innovative dietary supplement, GluteGuard®, for gluten digestion

Our Philosophy

Enhancing lives through innovation

At Glutagen, our mission is to help all people who experience gluten digestion issues. We understand the significant impact gluten can have on quality of life and how challenging it can be to maintain a gluten-free diet. This is why we take seriously our commitment to providing the highest quality complementary medicines for gluten digestion.

For decades, our team has contributed fundamental knowledge to the global science of gluten digestion. Since the establishment of Glutagen in 2001, our scientists have further advanced gluten intolerance research – particularly in the area of digestive enzymes – with the discovery that caricain, a natural enzyme found in the fruit oleoresin of the Carica papaya plant, can break down gluten peptides into smaller, harmless fragments.

With dedication to evidence-based biopharmaceutical innovation at the forefront of its research, Glutagen has developed and patented the natural enzyme action of GluteGuard.

GluteGuard is supported by world-first clinical studies. As a fully Australian-owned and operated company, we are proud to support health and wellbeing through the provision of dietary supplements that are developed and manufactured in Australia with the highest global quality standards (Good Manufacturing Practice, GMP).

Our continuing investment in gluten intolerance research is important, as the scientific and clinical advancements of today are sure to become the solutions that help gluten-sensitive and gluten-intolerant individuals in the future.

In all that we do, we aim to foster awareness and understanding among the wider community about gluten digestion and the challenges of living with the symptoms of gluten digestion issues.

Read more about the science of GluteGuard

Our People

Dedicated to providing solutions for gluten digestion

Dr Ted Stelmasiak


With over 25 years of experience in the biopharmaceutical industry, Dr Stelmasiak (DVM, PhD, MACVSc) founded Glutagen to provide solutions for people suffering symptoms due to gluten intolerance. Having held appointments with the Polish Academy of Sciences (Warsaw), the Imperial Cancer Research Fund (London), The University of Hawaii, Honolulu (USA), the University of Melbourne and the Victorian Institute of Animal Science (AU), Dr Stelmasiak has published over 60 scientific papers, filed several patents and developed treatments for bacterial and viral gastroenteritis.

Glutagen Biochemist

Professor Hugh Cornell

Lead Consultant Biochemist

Prof. Cornell (PhD, FRACI) is a former Professor of Biological Chemistry at the RMIT University in Melbourne, AU, with a distinguished international career spanning over 40 years in gluten intolerance and coeliac disease research. Prof. Cornell has authored over 100 published scientific papers and presentations and has held appointments at Birmingham University (UK), University of Zurich (Switzerland), Karolinska Institute (Sweden) and Technical University (Germany). Prof. Cornell conducted founding work on the enzyme deficiency hypothesis in coeliac disease and holds several patents.